Adtec Healthcare Secures $12m Investment

LONDON - Rezul -- Adtec Healthcare Secures $12 Million Investment to Accelerate Global Growth

London, UK – 11 July 2025 – Adtec Healthcare Limited, a leader in Cold Plasma medical technology, has secured $12 million in investment from AIPO Fund (lead investor) and SG Biomedical. This funding will drive the company's global expansion, new product development, and entry into the U.S. market.

Adtec Healthcare spun out from Adtec Plasma Technology Co., Ltd. (Japan) in June 2023. With over 20 years of Cold Plasma expertise, it launched the first device of its kind, now used across Europe for wound care and infection control.

The investment will:

• Develop a next-generation Cold Plasma medical device
• Support FDA approval and U.S. launch
• Expand into new global markets
• Boost R&D and manufacturing

"We're entering a transformative period," said Mary McGovern, CEO. "This investment shows strong confidence in our vision to make Cold Plasma a global standard for wound care and infection control."

More on Rezul News

• "The U.S. is Running Out of Workers" – New Book Offers Urgent, Research-Backed Solution to the Workforce Crisis
• LandGate® Releases Q2 2025 U.S. Data Center Development Summary
• Sell Your House FAST: New Options Help Homeowners Exit Quickly, Without Repairs or Agents
• Dedeaux inks global logistics firm to long-term lease for newly built warehouse in Fontana, CA
• Macon's Historic Douglass Theatre Names Toni Simmons Henson as Artistic Director for Inaugural Series Celebrating the Spirit of American Theatre

"We've spent over 20 years refining this technology," added Francois Herbst, CTO. "This funding helps us expand access to non-antibiotic, non-invasive treatments where they're needed most."

"This is about strategic acceleration," said Jeiram Jeyaratnam, CBDO. "We're ready to grow partnerships, launch in the U.S., and reach new territories with strong partners by our side."

AIPO Fund and SG Biomedical bring valuable healthcare expertise and networks to help make Cold Plasma widely available for patients worldwide.

Legal counsel: Fieldfisher London

About Adtec Healthcare
Adtec Healthcare Limited is a UK-based medical technology company pioneering Cold Plasma treatments for infection control and chronic wound healing. Its Cold Plasma medical device was the first of its kind on the European market and is widely used in hospitals and clinics today.

📧 info@adtechealthcare.com
📞 +44 208 737 5500
🌐 www.adtechealthcare.com